Several experimental studies have shown an interaction between renin-a
ngiotensin-aldosterone system and erythropoiesis, while several clinic
al studies in essentially patients with chronic renal failure have rep
orted that ACE-inhibitor interfere with erythropoiesis. The clinical c
onsequences of this effect need to be determined before condemning ACE
-inhibitor use in this patients.